{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:20:15Z","timestamp":1760059215603,"version":"build-2065373602"},"reference-count":10,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>The introduction of COVID-19 vaccinations has significantly altered the course of the pandemic by markedly reducing the number of severe infection cases, hospitalizations, and deaths due to COVID-19. Elderly individuals constitute a particularly vulnerable group at risk of severe disease progression, which is often related to decreased immune system effectiveness and comorbidities. Severe infection outcomes in vaccinated individuals, though substantially rarer than in the unimmunized population, can still lead to death due to underlying health conditions. This analysis aims to describe the population of elderly individuals who, despite being vaccinated, died from interstitial pneumonia complicating SARS-CoV-2 infection. Data on the infection course and co-existing diseases were obtained from the database of the J\u00f3zef Stru\u015b Multispecialty City Hospital in Pozna\u0144, which was converted into a dedicated facility during the pandemic. The inclusion criteria for the analysis were being over 60 years of age on the day of hospital admission, confirmed pneumonia in radiological examination, COVID-19 infection confirmed by PCR test, and an adverse disease course resulting in death. Patients admitted to the hospital from 1 June 2021 to 31 December 2021 were analyzed. Out of all hospitalizations, only 18 individuals met the inclusion criteria. Given the small number of patients, the authors employed descriptive methods to illustrate the clinical states of the individual patients, presenting SARS-CoV-2 infection in the context of co-existing diseases that significantly affect prognosis. The qualitative analysis employed highlights the complex and multidimensional courses of severely ill COVID-19 patients more emphatically.<\/jats:p>","DOI":"10.3390\/life15060879","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:22:41Z","timestamp":1748596961000},"page":"879","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of Hospitalized Elderly Patients with Severe Pneumonia Due to SARS-CoV-2, Vaccinated Against COVID-19"],"prefix":"10.3390","volume":"15","author":[{"given":"Jakub","family":"Kisiel","sequence":"first","affiliation":[{"name":"Multispecialist Municipal Hospital, J. Stru\u015b Memorial Hospital, Szwajcarska 3, 61-285 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Chojnicki","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Poznan University of Medical Sciences, Rokietnicka 10, 60-806 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arleta","family":"Kowala-Piaskowska","sequence":"additional","affiliation":[{"name":"Department and Clinic of Infectious Diseases, Hepatology and Acquired Immunodeficiencies, Poznan University of Medical Sciences, Szwajcarska 3, 61-285 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Wieczorowska-Tobis","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Poznan University of Medical Sciences, 61-285 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-3258","authenticated-orcid":false,"given":"S\u0142awomir","family":"Tobis","sequence":"additional","affiliation":[{"name":"Department of Occupational Therapy, Poznan University of Medical Sciences, 60-781 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1434-2138","authenticated-orcid":false,"given":"Urszula","family":"Religioni","sequence":"additional","affiliation":[{"name":"School of Public Health, Centre of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8966-3799","authenticated-orcid":false,"given":"Piotr","family":"Merks","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszy\u0144ski University, 01-815 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-7430","authenticated-orcid":false,"given":"Agnieszka","family":"Neumann-Podczaska","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Poznan University of Medical Sciences, 61-285 Poznan, Poland"},{"name":"Senior Institute, University of Economics and Humans Sciences in Warsaw, 01-043 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"p1041","DOI":"10.1136\/bmj.p1041","article-title":"COVID-19: WHO declares end of global health emergency","volume":"381","author":"Wise","year":"2023","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ayouni, I., Maatoug, J., Dhouib, W., Zammit, N., Fredj, S.B., Ghammam, R., and Ghannem, H. (2021). Effective public health measures to mitigate the spread of COVID-19: A systematic review. BMC Public Health, 21.","DOI":"10.1186\/s12889-021-11111-1"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.18632\/aging.103344","article-title":"Why does COVID-19 disproportionately affect older people?","volume":"12","author":"Mueller","year":"2020","journal-title":"Aging"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1056\/NEJMoa2114228","article-title":"Waning immunity after the BNT162b2 vaccine in Israel","volume":"385","author":"Goldberg","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (2025, May 27). Use of Additional Doses of 2024\u20132025 COVID-19 Vaccine for Adults Aged \u226565 Years and Persons Aged \u22656 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices\u2014United States, Available online: https:\/\/www.cdc.gov\/mmwr\/volumes\/73\/wr\/mm7349a2.htm.","DOI":"10.15585\/mmwr.mm7349a2"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: A literature review and meta-analysis","volume":"114","author":"Zheng","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"eabj1031","DOI":"10.1126\/sciimmunol.abj1031","article-title":"Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients","volume":"6","author":"Choi","year":"2021","journal-title":"Sci. Immunol."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/6\/879\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:43:36Z","timestamp":1760031816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/6\/879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":10,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["life15060879"],"URL":"https:\/\/doi.org\/10.3390\/life15060879","relation":{},"ISSN":["2075-1729"],"issn-type":[{"type":"electronic","value":"2075-1729"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}